Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Circ Genom Precis Med. 2021 Oct 28;14(6):e003421. doi: 10.1161/CIRCGEN.121.003421

Table 4.

Single nucleotide variants identified by GWAS associated with suPAR

Unconditioned analysis Stepwise conditional analysis MAF (1000 Genomes)

SNV Annotation Chr build37 A1/A2 MAF
(JHS)
p-value β 95% CI p-value β 95% CI Afr. Eur.
rs399145 (Signal A) p.Thr86Ala, PLAUR 19 44169522 T/C 0.11 2.0×10−78 0.73 0.65, 0.81 - - - 0.12 0.00
rs73935023 (Signal B) intronic, PLAUR 19 44178955 T/C 0.04 1.1×10−16 −0.55 −0.69, −0.41 2.3×10−14 −0.50 −0.64, −0.36 0.03 0.00
rs4251805 (Signal C) 5’ UTR, PLAUR 19 44174441 C/T 0.08 1.8×10−14 −0.36 −0.46, −0.26 8.6×10−13 −0.34 −0.44, −0.24 0.09 0.03
rs4760 (Signal D) p.Leu317Pro, PLAUR 19 44153100 A/G 0.03 3.9×10−04 0.27 0.11, 0.43 2.5×10−06 0.36 0.20, 0.52 0.00 0.16

Single nucleotide variants (SNVs) associated with suPAR before (unconditioned analysis) and after stepwise, forward-selection conditional analysis in participants of the Jackson Heart Study using ELISA-based suPAR levels (n=3492). Beta values and 95% confidence intervals (CI) represent the change in # of SD units of ln-transformed suPAR associated with a single copy of the minor (A2) allele. Minor allele frequencies (MAFs) are for Jackson Heart Study (JHS) participants, as well as African (Afr) and European (Eur) ancestry individuals in 1000 Genomes Phase 1. Chr, chromosome; UTR, untranslated region.